A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
Clinical trial NCT03374085 · TERMINATED
Trial details
- NCT number
- NCT03374085
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2025-08-20
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.